12


/ Press Releases
2019.07
TWi's ANDA for Fenofibric Acid DR Capsules has been approved by US FDA
2019.05
TWi successfully launches generic Diltiazem HCl ER Capsules in TWi label
2019.03
TWi successfully launches generic Cyclobenzaprine HCL ER Capsules in TWi label
2019.01
TWi's ANDA for Dimethyl Fumarate DR Capsules has been tentatively approved by US FDA
2019.01
TWi successfully launches generic Labetalol HCl Tablets in TWi label